… to have a high diagnostic yield in patients with solitary pulmonary nodules and in staging
of non-small-cell lung cancer (NSCLC) [3]. Studies have indicated that positron emission …

… to lung carcinoma. In the present study, UIP patients with or without lung carcinoma differed
… When we compared lung carcinomas in UIP and non-UIP patients, the increased frequency …

… Combination chemotherapy, generally platinum-based plus etoposide or irinotecan, is the
mainstay first-line treatment for metastatic small-cell lung cancer. For non-metastatic disease, …

… (11) conducted a retrospective study to compare the number of dissected lymph nodes and
… pathological data from patients with stage I non-small cell lung cancer patients. The results …

… cell lung cancer (NSCLC) accounts for ∼80% of all cases of lung cancer and it is estimated
that ∼55% of patients present with inoperable disease at the time of diagnosis [stage tumor–…

… patient was known to be alive. Some patients in this study had been enrolled in our previous
study, … benefit of gefitinib in chemotherapy-naive patients with NSCLC.22 The investigators …

… in patients with non-small-cell lung cancer. These procedures are especially helpful in the
preoperative evaluation of patients with … Accurate staging of non-small-cell lung cancer plays a …

… Elective nodal irradiation (ENI) and involved field radiotherapy (IFRT) are definitive
radiotherapeutic approaches used to treat patients with locally advanced non-small cell lung cancer (…

… treatment of small cell lung cancer. Cancer Treat Rep 1985; 69:43-6. 33. Smith IE, Evans BD.
… in the treatment of small cell lung cancer. Cancer Treat Rev (Suppl A) 1985; 12: 73-5. 34. …

… treatment offered for patients with stage IV disease, 1 although there have been no comparative
studies specifically conducted on these patients. … , in most cases, included patients with …